We discovered that ACSL3 is substantially associated with the immune checkpoint inhibitors PD-1, PD-L1, CTLA4, LAG3, and HAVCR2 in renal clear cell carcinoma. This evidence concerns the gene HAVCR2 and clear cell renal carcinoma.